Influence of prostaglandin E2 on hypertrophy in H9c2 cardiac cells

Abstract

Abstract: AIM: To explore the effects of PGE2 on cardiomyocyte through experiments on the cultured H9c2 cardiac cells, assess the dose-effect relationship to provide the basic theory for looking for potential targets of inhibiting myocardial hypertrophy.METHODS: H9c2 cardiac cells were randomly divided into four groups: control group (group C), 0.1 μmol/L PGE2 group (group D1), 1 μmol/L PGE2 group (group D2) and 10 μmol/L PGE2 group (group D3). Forty-eight hours later after PGE2 was fed, the morphology of H9c2 cardiac cells were recorded by using a fluorescence microscope. The occurrence of myocardial hypertrophy was observed in terms of cell diameter and total protein of the cells. And the gene expression levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) mRNA in cells, which were measured by RT-PCR, helped to judge whether there was an occurrence of pathological myocardial hypertrophy.RESULTS: Compared with group C, the cell shape changed and the volume increased, the cell diameter and the total protein were increased in group D1, group D2 and group D3 (P<0.05). There were also significant differences between different doses of PGE2 (P<0.05); the expression levels of ANP and BNP mRNA were upregulated in group D2 and group D3 compared with group C (P<0.05).CONCLUSION: PGE2 can induce myocardial hypertrophy of the cultured H9c2 cardiac cells in a dose-dependent manner. Larger dose of PGE2 stimulate pathological myocardial hypertrophy. Inhibition of PGE2 is expected to be a new target to control myocardial hypertrophy.

Key words: Prostaglandin E2, Cycloxygenase, Myocardial hypertrophy

CLC Number:

DAI Heng, ZUO Zhong, CHEN Ping, GAO Jin, XIONG Qiu-ju. Influence of prostaglandin E2 on hypertrophy in H9c2 cardiac cells[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(7): 721-724.

References

[1] 俞慧宏, 吴小翎, 张苜, 等. 测定胃癌患者肿瘤组织与外周血中前列腺素E2的临床意义[J]. 第三军医大学学报, 2008, 30(5): 444-446.
[2] Murakami M, Naraba H, Tanioka T, et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2[J]. J Biol Chem, 2000, 275(42): 32783-32792.
[3] Zamorano B, Carmona MT. Prostaglandin-E2 and cyclic adenosine 3'-5' monophosphate levels in the hypertrophied rat heart[J]. Biol Res, 1992, 25(2): 85-89.
[4] Liu CJ, Cheng YC, Lee KW, et al. Lipopolysaccharide induces cellular hypertrophy through calcineurin NFAT-3 signaling pathway in H9c2 myocardiac cells[J]. Mol Cell Biochem, 2008, 313(1/2): 167-178.
[5] 苏湲淇, 董志. 环氧合酶-2抑制剂防治阿尔茨海默氏病的进展[J]. 中国临床药理学与治疗学, 2003, 8(3): 249-251.
[6] 杨光锐, 管又飞. 前列腺素E2合酶的研究进展[J]. 生理科学进展, 2006, 37(2): 182-186.
[7] 王社临, 方五旺, 陈绍良. Bosentan对培养乳鼠心肌细胞肥大的抑制作用[J]. 中国临床药理学与治疗学, 2003, 8(1): 71-74.
[8] Almeida SS, Azevedo A, Castro A, et al. B-type natriuretic peptide is related to left ventricular mass in hypertensive patients but not in athletes[J]. Cardiology, 2002, 98(3): 113-115.
[9] 成宁宁,高进,戴珩,等. 帕瑞昔布联合右颈交感干离断对心肌梗死大鼠心室重构的影响[J]. 中国新药与临床杂志, 2011, 30(2): 122-124.
[10] Frias MA, Rebsamen MC, Gerber-Wicht C, Lang U. Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: a role in cardiac hypertrophy [J]. Cardiovasc Res, 2007, 73(1): 57-65.
[11] 齐敏友, 夏绘晶, 戴德哉. 灯盏花素对异丙肾上腺素所致小鼠心肌肥大的保护作用[J]. 中国临床药理学与治疗学, 2006, 11(3): 273-276.
[12] LaPointe MC, Mendez M, Leung A, et al. Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse[J]. Am J Physiol Heart Circ Physiol, 2004, 286(4): H1416-H1424.
[13] Cunnington M, Webb D, Qizilbash N, et al. Risk of ischaemic cardiovascular events from selective cyclooxygenase-2 inhibitors in osteoarthritis [J]. Pharmacoepidemiol Drug Saf, 2008, 17(6): 601-608.
[14] Sorensen R, Abildstrom SZ, Torp-Pedersen C, et al. Use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs in high doses increases mortality and risk of reinfarction in patients with prior myocardial infarction[J]. J Cardiovasc Nurs, 2008, 23(1): 14-19.